Results 31 to 40 of about 212,262 (290)

Late-manifestation of attention-deficit/hyperactivity disorder in older adults: an observational study

BMC Psychiatry, 2022
Background The age of attention-deficit/hyperactivity disorder onset is usually during the first 12 years of life; however, there have been recent reports of late-onset attention-deficit/hyperactivity disorder.
Hiroyuki Sasaki, Tadashi Jono, Ryuji Fukuhara, Kazuki Honda, Tomohisa Ishikawa, Shuken Boku, Minoru Takebayashi   +6 more
doaj   +1 more source

Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis

BMC Psychiatry, 2020
Background Emotional symptoms are increasingly considered a core feature of attention deficit/hyperactivity disorder (ADHD). We aimed to quantify the evidence of emotional dysregulation and its respective facets in individuals with adult ADHD compared to
A. Beheshti, Mira-Lynn Chavanon, H. Christiansen   +2 more
semanticscholar   +1 more source

High rate of attention deficit hyperactivity disorder among children 6 to 17 years old in Southwest Ethiopia findings from a community-based study

BMC Psychiatry, 2023
Background Attention-deficit/hyperactivity disorder is among the common neuropsychiatric disorders affecting children and adolescents. The disorder affects the life of children, their parents, and the community when left untreated.
Kemal Aliye, Elias Tesfaye, Matiwos Soboka   +2 more
doaj   +1 more source

Raising Awareness about Adult Autism Spectrum Disorder

Acta Médica Portuguesa, 2021
N/a.
Tomás Teodoro, José Salgado
doaj   +1 more source

Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Pediatrics, 2019
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurobehavioral disorders of childhood and can profoundly affect children’s academic achievement, well-being, and social interactions.
M. Wolraich, J. Hagan, Carla C. Allan, Eugenia Chan, Dale Davison, Marian F. Earls, Steven W. Evans, Susan K. Flinn, Tanya E. Froehlich, Jennifer L Frost, Joseph R Holbrook, Christoph U. Lehmann, H. Lessin, Kymika Okechukwu, Karen L. Pierce, Jonathan D. Winner, W. Zurhellen   +16 more
semanticscholar   +1 more source

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

Lancet psychiatry, 2018
Summary Background The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) remain controversial, and guidelines are inconsistent on which medications are preferred across different age groups.
S. Cortese, N. Adamo, C. Del Giovane, Christina Mohr-Jensen, A. Hayes, S. Carucci, L. Atkinson, Luca Tessari, T. Banaschewski, D. Coghill, C. Hollis, E. Simonoff, A. Zuddas, C. Barbui, M. Purgato, H. Steinhausen, F. Shokraneh, Jun Xia, A. Cipriani   +18 more
semanticscholar   +1 more source

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Medical Clinics of North America, 2001
ADHD continues to be one of the most common psychiatric disorders in children and is recognized increasingly as a common psychiatric disorder in adults. Diagnosis of the disorder requires careful consideration of other psychiatric and medical disorders that may mimic symptoms of ADHD.
J B, Schweitzer, T K, Cummins, C A, Kant
openaire   +5 more sources

Genetics of attention deficit hyperactivity disorder

Molecular Psychiatry, 2018
Decades of research show that genes play an vital role in the etiology of attention deficit hyperactivity disorder (ADHD) and its comorbidity with other disorders. Family, twin, and adoption studies show that ADHD runs in families.
S. Faraone, H. Larsson
semanticscholar   +1 more source

The Pharmacology of Amphetamine and Methylphenidate: Relevance to the Neurobiology of Attention-Deficit/Hyperactivity Disorder and Other Psychiatric Comorbidities

Neuroscience and Biobehavioral Reviews, 2018
HighlightsThis review discusses amphetamine (AMP) and methylphenidate (MPH) pharmacology.AMP and MPH increase corticostriatal catecholamine availability in different ways.Catecholamine alterations occur in attention‐deficit/hyperactivity disorder (ADHD ...
S. Faraone
semanticscholar   +1 more source

ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) – THERAPY [PDF]

Romanian Journal of Pediatrics, 2008
In the article there are presented: prevalence; pathophysiology; diagnosis; treatment (conventional therapy and complementary and alternative medicine – CAM); integrative ...
Valeriu Popescu
doaj   +1 more source